Role of CD58 in minimal residual disease detection of ALL patients at South Egypt Cancer Institute

Clinico-Hematologic Profile of Chronic Lymphocytic Leukemia inEgypt: A Three-Center Experience

Expression of aberrant markers in acute leukemia at South Egypt Cancer Institute: A retrospective study

Impact of the Clinicolaboratory Characteristics on the Treatment Outcome of the Pediatric Patients with Acute Lymphoblastic Leukemia at South Egypt Cancer Institute

Prognostic Significance of 13q14 Deletion in Egyptian Chronic Lymphocytic Leukemia Patients

The Use of CD200 as a diagnostic marker in Egyptian patients with Chronic Lymphoproliferative Disorders

Demographic data in patients with Chronic Lymphocytic Leukemia

Clinicolaboratory Characteristics and Outcome of Pediatric Acute Lymphoblastic Leukemia in a Resource-Limited Setting: A Study from South Egypt

Significance of Interleukin-22 and CD38 in Chronic Lymphocytic Leukemia

Prognostic Value of Soluble HLA-G and CD38 Expression in Patients with Chronic Lymphocytic Leukemia in Egypt